What's new

Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 13:00 (CET) to 6 March 2025, 15:30 (CET)

Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 13:00 (CET) to 6 March 2025, 15:30 (CET)

Mar 14, 2025 - 13:47
 0
Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 13:00 (CET) to 6 March 2025, 15:30 (CET)
Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 13:00 (CET) to 6 March 2025, 15:30 (CET)
Read More

Tags:

Previous Article

SEAT Martorell EV transformation a “near reality”

Next Article

New approach to EU trade needed as import and export gap widens

Related Posts

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Date of authorisation: 26/08/1997, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0